Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.81
0.00 (0.00%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.23 billion as of July 6, 2026. Its market cap has increased by 104.25% in one year.
Market Cap
3.23B
Enterprise Value
3.12B
1-Year Change
104.25%
Ranking
Category
Stock Price
$25.81
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.23B, an increase of 312.82%. That is a compound annual growth rate of 24.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 3.23B | -9.24% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IDEAYA Biosciences | 3.58B |
| Enliven Therapeutics | 3.48B |
| Beam Therapeutics | 3.46B |
| Alumis | 3.38B |
| Ultragenyx Pharmaceutical | 3.29B |
| Celldex Therapeutics | 3.01B |
| Vera Therapeutics | 2.96B |
| Disc Medicine | 2.91B |